BRCA1/2-related breast cancers

Trending

Sign Up for The Oncology Newsletter | Our free weekly news roundup
‘Hope’ isn’t mere wishful thinking – it’s a valuable tool we can put to work in a crisis
ESMO 2020: Immunotherapy is beneficial in gastric and oesophageal cancers
ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
ESMO 2020: Research breakthrough offers new hope for high risk patients with HR+ breast cancer
ESMO 2020: Step forward in treatment for patients with newly diagnosed advanced ovarian cancer
Mathematical model maps out ‘arms race’ between cancer and immune system and predicts effectiveness of immunotherapy
NSW introduces skin cancer prevention to school curriculum
ESMO 2020: Amivantamab with lazertinib in patients with EGFR-mutated non-small cell lung cancer

RSS
Facebook
Twitter
LinkedIn

Podcasts
Features
Featured

‘Hope’ isn’t mere wishful thinking – it’s a valuable tool we can put to work in a crisis

September 22, 2020

Recent

‘Hope’ isn’t mere wishful thinking – it’s a valuable tool we can put to work in a crisis
September 22, 2020 0

ESMO 2020: Immunotherapy is beneficial in gastric and oesophageal cancers
September 22, 2020 0

ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
September 22, 2020 0
Popular
Featured

NSW introduces skin cancer prevention to school curriculum

September 22, 2020

Recent

NSW introduces skin cancer prevention to school curriculum
September 22, 2020 0

ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
September 22, 2020 0

ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early breast cancer
September 21, 2020 0
News In Focus
Tumour
Company News
More

Podcasts
Features
Featured

‘Hope’ isn’t mere wishful thinking – it’s a valuable tool we can put to work in a crisis

September 22, 2020

Recent

‘Hope’ isn’t mere wishful thinking – it’s a valuable tool we can put to work in a crisis
September 22, 2020 0

ESMO 2020: Immunotherapy is beneficial in gastric and oesophageal cancers
September 22, 2020 0

ESMO 2020: Two-pronged attack using new targeted drug could treat ‘addicted’ prostate cancers
September 22, 2020 0
Popular
Featured

NSW introduces skin cancer prevention to school curriculum

September 22, 2020

Recent

NSW introduces skin cancer prevention to school curriculum
September 22, 2020 0

ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
September 22, 2020 0

ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early breast cancer
September 21, 2020 0
News In Focus
Tumour
Company News
More

You are at:Home»Posts Tagged "BRCA1/2-related breast cancers"

Browsing: BRCA1/2-related breast cancers

Breast Cancer

Research provides insight into genetic link to potential treatment response among BRCA1/2 breast cancer patients

May 24, 2019

New findings from researchers in the Perelman School of Medicine at the University of Pennsylvania…

Subscribe for News Updates
Search Oncology News
Search for:
Speak your mind!

Passionate about a development that deserves more attention? Views on a controversial issue?

Oncology News publishes commentary pieces from oncology professionals here and in The Oncology Newsletter.

Contact us to discuss

Subscribe for News Updates

The Oncology Newsletter is a free publication distributed to healthcare professionals every week, featuring news, views, reviews and the latest jobs. Subscribe.
About Us

Oncology News Australia is a small group of publishing, media and digital professionals providing resources for the oncology community. More information.
Advertising with Us

If you seek to connect and present your product or service to an engaged oncology healthcare community, you have come to the right place. More information.

© Oncology News Australia | info@oncologynews.com.au

Sign In

Log In

Lost password?

Don't have an account? Register Now!

Recover Password

Recover Password

Register

Log In

A password will be e-mailed to you.